A citation-based method for searching scientific literature

Liran Zhou, Keiko Hosohata, Shen Gao, Zhongping Gu, Zhengxin Wang. PLoS One 2013
Times Cited: 4







List of co-cited articles
24 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Sm protein methyltransferase PRMT5 is not required for primordial germ cell specification in mice.
Ziwei Li, Juehua Yu, Linzi Hosohama, Kevin Nee, Sofia Gkountela, Sonal Chaudhari, Ashley A Cass, Xinshu Xiao, Amander T Clark. EMBO J 2015
20
50

Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
Sharmistha Pal, Sheethal N Vishwanath, Hediye Erdjument-Bromage, Paul Tempst, Saïd Sif. Mol Cell Biol 2004
425
50

Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains.
Nathalie Troffer-Charlier, Vincent Cura, Pierre Hassenboehler, Dino Moras, Jean Cavarelli. EMBO J 2007
107
50

PRMT5 protects genomic integrity during global DNA demethylation in primordial germ cells and preimplantation embryos.
Shinseog Kim, Ufuk Günesdogan, Jan J Zylicz, Jamie A Hackett, Delphine Cougot, Siqin Bao, Caroline Lee, Sabine Dietmann, George E Allen, Roopsha Sengupta,[...]. Mol Cell 2014
73
50

Targets in epigenetics: inhibiting the methyl writers of the histone code.
Julianne M Yost, Ilia Korboukh, Feng Liu, Cen Gao, Jian Jin. Curr Chem Genomics 2011
40
50

Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer.
Martin Ligr, Ruzeen Rohintan Patwa, Garrett Daniels, Lorraine Pan, Xinyu Wu, Yirong Li, Liantian Tian, Zhenxing Wang, Ruliang Xu, Jingjing Wu,[...]. PLoS One 2011
31
50

Structural biology and chemistry of protein arginine methyltransferases.
Matthieu Schapira, Renato Ferreira de Freitas. Medchemcomm 2014
44
50

The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins.
W J Friesen, S Paushkin, A Wyce, S Massenet, G S Pesiridis, G Van Duyne, J Rappsilber, M Mann, G Dreyfuss. Mol Cell Biol 2001
302
50

Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery.
Marco Bezzi, Shun Xie Teo, Julius Muller, Wei Chuen Mok, Sanjeeb Kumar Sahu, Leah A Vardy, Zahid Q Bonday, Ernesto Guccione. Genes Dev 2013
144
50

Arginine methylation regulates the p53 response.
Martin Jansson, Stephen T Durant, Er-Chieh Cho, Sharon Sheahan, Mariola Edelmann, Benedikt Kessler, Nicholas B La Thangue. Nat Cell Biol 2008
301
50

Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency.
Wee-Wei Tee, Mercedes Pardo, Thorold W Theunissen, Lu Yu, Jyoti S Choudhary, Petra Hajkova, M Azim Surani. Genes Dev 2010
212
50


Structural insights into protein arginine symmetric dimethylation by PRMT5.
Litao Sun, Mingzhu Wang, Zongyang Lv, Na Yang, Yingfang Liu, Shilai Bao, Weimin Gong, Rui-Ming Xu. Proc Natl Acad Sci U S A 2011
88
50

Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma.
Sharmistha Pal, Robert A Baiocchi, John C Byrd, Michael R Grever, Samson T Jacob, Saïd Sif. EMBO J 2007
193
50

Crystal structure of the human PRMT5:MEP50 complex.
Stephen Antonysamy, Zahid Bonday, Robert M Campbell, Brandon Doyle, Zhanna Druzina, Tarun Gheyi, Bomie Han, Louis N Jungheim, Yuewei Qian, Charles Rauch,[...]. Proc Natl Acad Sci U S A 2012
180
50

PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB.
Han Wei, Benlian Wang, Masaru Miyagi, Yun She, Banu Gopalan, De-Bin Huang, Gourisankar Ghosh, George R Stark, Tao Lu. Proc Natl Acad Sci U S A 2013
128
50

Protein arginine methyltransferases and cancer.
Yanzhong Yang, Mark T Bedford. Nat Rev Cancer 2013
566
50

The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression.
Zhaoyuan Hou, Hongzhuang Peng, Kasirajan Ayyanathan, Kai-Ping Yan, Ellen M Langer, Gregory D Longmore, Frank J Rauscher. Mol Cell Biol 2008
154
50

Protein arginine methylation in mammals: who, what, and why.
Mark T Bedford, Steven G Clarke. Mol Cell 2009
50

Versatility of PRMT5-induced methylation in growth control and development.
Vrajesh Karkhanis, Yu-Jie Hu, Robert A Baiocchi, Anthony N Imbalzano, Saïd Sif. Trends Biochem Sci 2011
158
50


PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins.
T L Branscombe, A Frankel, J H Lee, J R Cook, Z Yang , S Pestka, S Clarke. J Biol Chem 2001
275
50

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.
Jung-Mao Hsu, Chun-Te Chen, Chao-Kai Chou, Hsu-Ping Kuo, Long-Yuan Li, Chun-Yi Lin, Hong-Jen Lee, Ying-Nai Wang, Mo Liu, Hsin-Wei Liao,[...]. Nat Cell Biol 2011
146
50


The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue.
Roberta L Gonçalves, Claire Lugnier, Thérèse Keravis, Miguel J Lopes, Fernando A Fantini, Martine Schmitt, Steyner F Cortes, Virginia S Lemos. Eur J Pharmacol 2009
28
25

Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB.
Bjarte Skoe Erikstein, Emmet McCormack, Karl Johan Tronstad, Frank Schwede, Rolf Berge, Bjørn Tore Gjertsen. Leuk Res 2010
8
25

The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types.
C Christian Johansson, Arne Yndestad, Jorrit M Enserink, Anne H Ree, Pål Aukrust, Kjetil Taskén. Endocrinology 2004
30
25

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.
Sharron H Francis, Jennifer L Busch, Jackie D Corbin, David Sibley. Pharmacol Rev 2010
583
25

Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators.
F Flamigni, A Facchini, I Stanic, B Tantini, F Bonavita, C Stefanelli. Biochem Pharmacol 2001
17
25


Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
H M Wang, Z X Liao, R Komaki, J W Welsh, M S O'Reilly, J Y Chang, Y Zhuang, L B Levy, C Lu, D R Gomez. Ann Oncol 2013
131
25

Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.
D Marko, G Pahlke, K H Merz, G Eisenbrand. Chem Res Toxicol 2000
31
25

Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
S A Waldman, M Barber, J Pearlman, J Park, R George, S J Parkinson. Cancer Epidemiol Biomarkers Prev 1998
37
25


PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP.
Richard Lee, Sharon Wolda, Eunyi Moon, James Esselstyn, Carmen Hertel, Adam Lerner. Cell Signal 2002
67
25

Prostanoids and cyclic nucleotides in malignant and benign ovarian tumors.
P K Heinonen, T Metsä-Ketelä. Med Oncol Tumor Pharmacother 1988
9
25

Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Faranak Fallahian, Fatemeh Karami-Tehrani, Siamak Salami, Mahmoud Aghaei. FEBS J 2011
64
25

Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia.
Patrick R Verhoest, Douglas S Chapin, Michael Corman, Kari Fonseca, John F Harms, Xinjun Hou, Eric S Marr, Frank S Menniti, Frederick Nelson, Rebecca O'Connor,[...]. J Med Chem 2009
172
25

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.
Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desiree Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van't Veer, Jacques Neefjes. Cancer Cell 2004
202
25

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.
Andrew T Bender, Joseph A Beavo. Pharmacol Rev 2006
25


Bacterial enterotoxins are associated with resistance to colon cancer.
G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
116
25

Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients.
Anna Kobsar, Sonja Heeg, Katharina Krohne, Andreas Opitz, Ulrich Walter, Markus Böck, Stepan Gambaryan, Martin Eigenthaler. Stem Cells Dev 2008
16
25

Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
L Liu, H Li, T Underwood, M Lloyd, M David, G Sperl, R Pamukcu, W J Thompson. J Pharmacol Exp Ther 2001
75
25

Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: comradeship and hostility.
Nancy Gerits, Sergiy Kostenko, Alexey Shiryaev, Mona Johannessen, Ugo Moens. Cell Signal 2008
126
25

Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase.
S D Idriss, T Gudi, D E Casteel, V G Kharitonov, R B Pilz, G R Boss. J Biol Chem 1999
63
25

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
127
25


Patterns of brain glucose metabolism induced by phosphodiesterase 10A inhibitors in the mouse: a potential translational biomarker.
Stefanie Dedeurwaerdere, Cindy Wintmolders, Greet Vanhoof, Xavier Langlois. J Pharmacol Exp Ther 2011
17
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.